Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2006

01-11-2006 | Laboratory Investigation

Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid

Authors: Peter Heiduschka, Solon Thanos

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2006

Login to get access

Abstract

Background

Neuroprotection is essential for repair processes after a traumatic insult in the central nervous system. We have demonstrated previously significant neuroprotective properties of the anti-apoptotic drug aurintricarboxylic acid in the model of axotomised retinal ganglion cells. Glucocorticoids are widely used to treat injuries of the nervous system. Due to the anti-inflammatory and microglia-inhibiting properties of glucocorticoids, we studied the neuroprotective effects of intravitreally administered cortisol after an optic nerve cut.

Methods

Ninety-eight adult Sprague–Dawley rats were used in this study. The optic nerve was cut intra-orbitally. Either vehicle or compound solution was injected intravitreally. Fluorescent dye was put onto the optic nerve stump to label retinal ganglion cells retrogradely. Retinal whole mounts were prepared 2 weeks after axotomy, and surviving retinal ganglion cells were counted.

Results

Two weeks after axotomy, up to 50±7% of all retinal ganglion cells survived if cortisol was injected into the eye compared with 17±5% survival if only vehicle solution was injected. The neuroprotective effects of aurintricarboxylic acid (43±5% survival) could be further enhanced if combined with cortisol (up to 61±5% survival). Regeneration of cut retinal ganglion cell axons into a peripheral nerve graft could also be enhanced by an intravitreal injection of cortisol (169±42 regenerating retinal ganglion cells per mm2 vs. 73±12 cells per mm2 after vehicle injection). The increase was not as high as with aurintricarboxylic acid (192±40 cells per mm2), although more retinal ganglion cells survived with cortisol. This indicates that neuronal survival alone is not sufficient for subsequent axonal regeneration. Nevertheless, regeneration could be markedly increased if aurintricarboxylic acid and cortisol were combined (308±72 cells per mm2).

Conclusions

Whereas aurintricarboxylic acid seems to act directly on lesioned retinal ganglion cells, cortisol seems to act on the glial environment, as indicated by microglial cell morphology and enhanced glial fibrillary acidic protein expression. The results show that both neuroprotection and regeneration can be enhanced by the combination of two simple compounds acting on different sites.
Literature
1.
Almeida OF, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AH, Meyer M, Holsboer F, Michaelidis TM (2000) Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 14:779–790PubMed
2.
Amin AR, Vyas P, Attur M, Leszczynska-Piziak J, Patel IR, Weissmann G, Abramson SB (1995) The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Nat Acad Sci USA 92:7926–7930PubMedCrossRef
3.
Armaly MF (1965) Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol 4:187–197PubMed
4.
5.
Barr CS, Dokas LA (1999) Glucocorticoids regulate the synthesis of HSP27 in rat brain slices. Brain Res 847:9–17CrossRefPubMed
6.
Becker KW, Kienecker E-W, Andrae I (1987) Einfluβ lokal applizierter Kortikoide auf die Morphologie peripherer Nerven nach Neurotmesis und mikrochirurgischer Naht. Neurochirurgia 30:161–167PubMed
7.
Bianchi M, Meng C, Ivashkiv LB (2000) Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc Nat Acad Sci USA 97:9573–9578CrossRefPubMed
8.
Biola A, Andréau K, David M, Sturm M, Haake M, Bertoglio J, Pallardy M (2000) The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS Lett 487:229–233CrossRefPubMed
9.
Boldrey E, Giansiracusa J, Beltran P (1951) The effect of cortisone and ACTH on scarring in the brain and in peripheral nerves. Surg Forum 2:386–388
10.
Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W (1997) Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277:1597–1604CrossRefPubMed
11.
Braughler JM, Hall ED (1985) Current application of “high-dose” steroid therapy for CNS injury. J Neurosurg 62:806–810PubMedCrossRef
12.
Carnahan MC, Goldstein DA (2000) Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 11:478–483PubMedCrossRef
13.
Castaño A, Lawson LJ, Fearn S, Perry VH (1996) Activation and proliferation of murine microglia are insensitive to glucocorticoids in Wallerian degeneration. Eur J Neurosci 8:581–588PubMedCrossRef
14.
Chan TK, Wong JS, Ram RS, Amrith S (1996) Visual recovery following treatment with very high dose corticosteroid in traumatic optic neuropathy. Singapore Med J 37:216–217PubMed
15.
Chao TC, Van Alten PJ, Walter RJ (1994) Steroid sex hormones and macrophage function: modulation of reactive oxygen intermediates and nitrite release. Am J Reprod Immunol 32:43–52PubMed
16.
Chaum E (2003) Retinal neuroprotection by growth factors: a mechanistic perspective. J Cell Biochem 88:57–75CrossRefPubMed
17.
Chen C-W, Chao Y, Chang Y-H, Hsu M-J, Lin W-W (2002) Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid. Br J Pharmacol 137:1011–1020CrossRefPubMed
18.
Coleman WP, Benzel D, Cahill DW, Ducker T, Geisler F, Green B, Gropper MR, Goffin J, Madsen PW 3rd, Maiman DJ, Ondra SL, Rosner M, Sasso RC, Trost GR, Zeidman S (2000) A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 13:185–199CrossRefPubMed
19.
20.
De Nicola AF, Ferrini M, Gonzalez SL, Gonzalez Deniselle MC, Grillo CA, Piroli G, Saravia F, de Kloet ET (1998) Regulation of gene expression by corticoid hormones in the brain and spinal cord. J Steroid Biochem Mol Biol 65:253–272CrossRefPubMed
21.
Derouiche A, Rauen T (1995) Coincidence of L-glutamate/L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearance. J Neurosci Res 42:131–143CrossRefPubMed
22.
Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R, Bähr M (2003) Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci 23:6993–7000PubMed
23.
Drew PD, Chavis JA (2000) Inhibition of microglial cell activation by cortisol. Brain Res Bull 52:391–396CrossRefPubMed
24.
Farkas RH, Grosskreutz CL (2001) Apoptosis, neuroprotection, and retinal ganglion cell death: an overview. Int Ophthalmol Clin 41:111–130CrossRefPubMed
25.
Ganter S, Northoff H, Mannel D, Gebicke-Haerter PJ (1992) Growth control of cultured microglia. J Neurosci Res 33:218–230CrossRefPubMed
26.
Garcia-Zambrano W, Gonzáles-Angulo A, Rivas A, Mateos-Gómez JH (1982) Effect of dexamethasone on healing of sutured arteries and nerves. Arch Invest Med (Mex) 13:157–166
27.
Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13:2061–2070PubMed
28.
Gorovits R, Avidan N, Avisar N, Shaked I, Vardimon L (1997) Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. Proc Nat Acad Sci USA 94:7024–7029CrossRefPubMed
29.
Graham WP III, Pataky PE, Calabretta AM, Munger BL, Buda MJ (1973) Enhancement of peripheral nerve regeneration with triamcinolone after neurorraphy. Surg Forum 24:457–459PubMed
30.
Heiduschka P, Thanos S (2000) Restoration of the retinofugal pathway. Progr Retin Eye Res 19:577–606CrossRefPubMed
31.
Heiduschka P, Thanos S (2000) Aurintricarboxylic acid promotes survival and regeneration of axotomised retinal ganglion cells in vivo. Neuropharmacology 39:889–902CrossRefPubMed
32.
Heiduschka P, Fischer D, Thanos S (2004) Neuroprotection and regeneration after traumatic lesion of the optic nerve. Klin Monatsbl Augenheilkd 221:684–701CrossRefPubMed
33.
Huang ZB, Eden E (1993) Effect of corticosteroids on IL1 β and TNF α release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 104:751–755PubMed
34.
Kaur C, Wu CH, Wen CY, Ling EA (1994) The effects of subcutaneous injections of gluco-corticoids on amoeboid microglia in postnatal rats. Arch Histol Cytol 57:449–459PubMed
35.
Krueger-Naug AMR, Emsley JG, Myers TL, Currie RW, Clarke DB (2002) Injury to retinal ganglion cells induces expression of the small heat shock protein Hsp27 in the rat visual system. Neuroscience 4:653–665CrossRef
36.
Laping NJ, Teter B, Nichols NR, Rozovsky I, Finch CE (1994) Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol 1:259–275
37.
Lechner J, Welte T, Doppler W (1997) Mechanism of interaction between the glucocorticoid receptor and Stat5: role of DNA-binding. Immunobiology 198:112–123PubMed
38.
Maurel D, Sage D, Mekaouche M, Bosler O (2000) Glucocorticoids up-regulate the expression of glial fibrillary acidic protein in the rat suprachiasmatic nucleus. Glia 29:212–221CrossRefPubMed
39.
Morrison RS, de Vellis J, Lee YL, Bradshaw RA, Eng LF (1985) Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes. J Neurosci Res 14:167–176CrossRefPubMed
40.
Nichols NR, Osterburg HH, Masters JN, Millar SL, Finch CE (1990) Messenger RNA for glial fibrillary acidic protein is decreased in rat brain following acute and chronic corticosterone treatment. Mol Brain Res 7:1–7CrossRefPubMed
41.
O’Callaghan JP, Brinton RE, McEwen BS (1991) Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury. J Neurochem 57:860–869PubMedCrossRef
42.
Osborne NN, Chidlow G, Wood JPM, Schmidt K-G, Casson R, Melena J (2001) Expectations in the treatment of retinal diseases: neuroprotection. Curr Eye Res 22:321–332CrossRefPubMed
43.
Packan DR, Sapolsky RM (1990) Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. Neuroendocrinology 51:613–618PubMed
44.
Qian T, Campagnolo D, Kirshblum S (2000) High-dose methylprednisolone may do more harm for spinal cord injury. Med Hypotheses 55:452–453CrossRefPubMed
45.
Rauen T, Wieβner M (2000) Fine tuning of glutamate uptake and degradation in glial cells: common transcriptional regulation of GLAST1 and GS. Neurochem Int 37:179–189CrossRefPubMed
46.
Sheng Y, Zhu Y, Wu L (2004) Effect of high dosage of methylprednisolone on rat retinal ganglion cell apoptosis after optic nerve crush. Yan Ke Xue Bao 20:181–186PubMed
47.
Sherif Z, Pleyer U (2002) Corticosteroids in ophthalmology: past-present-future. Ophthalmologica 216:305–315CrossRefPubMed
48.
Short DJ, El Masry WS, Jones PW (2000) High dose methylprednisolone in the management of acute spinal cord injury—a systematic review from a clinical perspective. Spinal Cord 38:273–286CrossRefPubMed
49.
So E-Y, Kim S-H, Cho B-S, Park H-H, Lee C-E (2002) Corticosteroid inhibits IL-4 signaling through down-regulation of IL-4 receptor and STAT6 activity. FEBS Lett 518:53–59CrossRefPubMed
50.
Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ (1990) Treatment of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol 110:665–669PubMed
51.
Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing’s syndrome. Biol Psychiatry 32:756–765CrossRefPubMed
52.
Steinsapir KD, Goldberg RA, Sinha S, Hovda DA (2000) Methylprednisolone exacerbates axonal loss following optic nerve trauma in rats. Restor Neurol Neurosci 17:157–163PubMed
53.
Tanaka J, Fujita H, Matsuda S, Toku K, Sakanaka M, Maeda N (1997) Glucocorticoid and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Glia 20:23–37CrossRefPubMed
54.
Thanos S, Mey J, Wild M (1993) Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 13:455–466PubMed
55.
Thanos S, Kacza J, Seeger J, Mey J (1994) Old dyes for new scopes: the phagocytosis-dependent long-term fluorescence labelling of microglial cells in vivo. Trends Neurosci 17:177–182CrossRefPubMed
56.
57.
Van der Goes A, Hoekstra K, van den Berg TK, Dijkstra CD (2000) Dexamethasone promotes phagocytosis and bacterial killing by human monocytes/macrophages in vitro. J Leukoc Biol 67:801–807PubMed
58.
Vardimon L, Ben-Dror I, Avisar N, Oren A, Shiftan L (1999) Glucocorticoid control of glial gene expression. J Neurobiol 40:513–527CrossRefPubMed
59.
Vijayan VK, Cotman CW (1987) Hydrocortisone administration alters glial reaction to entorhinal lesion in the rat dentate gyrus. Exp Neurol 96:307–320CrossRefPubMed
60.
Zhao ZQ, Morris CD, Budde JM, Wang NP, Muraki S, Sun HY, Guyton RA (2003) Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res 59:132–142CrossRefPubMed
Metadata
Title
Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid
Authors
Peter Heiduschka
Solon Thanos
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2006
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-0164-7

Other articles of this Issue 11/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2006 Go to the issue

Case Report

Horizontal and vertical micropsia following macula-off rhegmatogenous retinal-detachment surgical repair

Clinical Investigation

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

Clinical Investigation

Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy

Clinical Investigation

Quantification of retinal nerve fiber layer thickness reduction associated with a relative afferent pupillary defect

Laboratory Investigation

Vascular changes in the posterior eye segment of secondary angle-closure glaucoma: cause or consequence?

Clinical Investigation

Dysfunction of transmission in the inner retina: incidence and clinical causes of negative electroretinogram